Managing Risks in Clinical Trials for Digital Health Tools
Researchers studied how to manage risks in clinical trials for a digital tool designed to help doctors make treatment decisions for epilepsy.
Easy summaries on neuromodulation for epilepsy—VNS, RNS, DBS—what studies show, risks, and “talk to your doctor” questions.
Researchers studied how to manage risks in clinical trials for a digital tool designed to help doctors make treatment decisions for epilepsy.
This study looked at the effects of responsive neurostimulation (RNS) on the brain function of patients with drug-resistant epilepsy (DRE).
This study looked at how effective vagus nerve stimulation (VNS) is for children with drug-resistant epilepsy (DRE), which means their seizures do not respond well to medications.
This study looked at how epilepsy caused by cavernous malformations in the brain is diagnosed and treated in Kazakhstan.
Researchers studied the use of two types of brain monitoring—scalp EEG (scEEG) and stereo EEG (SEEG)—in patients with drug-resistant epilepsy.
Researchers studied 231 children who experienced febrile seizures, which are seizures triggered by fever, to see if they could predict who might develop epilepsy or a specific type of epilepsy called genetic epilepsy with febrile seizures plus (GEFS+).
This study looked at how pediatric epilepsy centers in the United States make decisions about surgery for children with Lennox-Gastaut Syndrome (LGS), a severe type of epilepsy.
Researchers studied infantile epilepsy spasms syndrome (IESS), a serious condition that affects about 3 in 10,000 newborns in the U.S.
Researchers studied the effects of valproate, a medication used to treat epilepsy and bipolar disorder, on infertility in men.